DK1206448T3 - Nye vitamin D analoger - Google Patents
Nye vitamin D analogerInfo
- Publication number
- DK1206448T3 DK1206448T3 DK00943703T DK00943703T DK1206448T3 DK 1206448 T3 DK1206448 T3 DK 1206448T3 DK 00943703 T DK00943703 T DK 00943703T DK 00943703 T DK00943703 T DK 00943703T DK 1206448 T3 DK1206448 T3 DK 1206448T3
- Authority
- DK
- Denmark
- Prior art keywords
- analogues
- new vitamin
- vitamin
- phenyl
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14720099P | 1999-08-04 | 1999-08-04 | |
| PCT/DK2000/000389 WO2001010829A1 (en) | 1999-08-04 | 2000-07-11 | Novel vitamin d analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1206448T3 true DK1206448T3 (da) | 2004-08-09 |
Family
ID=22520639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00943703T DK1206448T3 (da) | 1999-08-04 | 2000-07-11 | Nye vitamin D analoger |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6573255B1 (da) |
| EP (1) | EP1206448B1 (da) |
| JP (2) | JP2003506435A (da) |
| KR (1) | KR20020022792A (da) |
| CN (1) | CN1167678C (da) |
| AT (1) | ATE265430T1 (da) |
| AU (1) | AU770771B2 (da) |
| CA (1) | CA2381910A1 (da) |
| CZ (1) | CZ2002392A3 (da) |
| DE (1) | DE60010276T2 (da) |
| DK (1) | DK1206448T3 (da) |
| ES (1) | ES2216908T3 (da) |
| HK (1) | HK1049148B (da) |
| HU (1) | HUP0202305A3 (da) |
| NZ (1) | NZ516913A (da) |
| PL (1) | PL364698A1 (da) |
| PT (1) | PT1206448E (da) |
| RU (1) | RU2228928C2 (da) |
| WO (1) | WO2001010829A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0117645D0 (en) * | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
| WO2005027930A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | 2-alkylene-19-nor-vitamin d derivatives for the treatment of osteosarcoma |
| US20050074443A1 (en) * | 2003-10-03 | 2005-04-07 | Treadwell Benjamin V. | Methods of attenuating autoimmune disease and compositions useful therefor |
| US8404667B2 (en) * | 2006-12-29 | 2013-03-26 | Wisconsin Alumni Research Foundation | Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog |
| KR20100082840A (ko) | 2007-09-27 | 2010-07-20 | 에스체아 히기에너 프로덕츠 악티에볼라그 | 클레이결합된 폴리머 겔 |
| CN103922984B (zh) * | 2014-04-24 | 2016-08-24 | 湖南华腾制药有限公司 | 西奥骨化醇的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5254799A (en) * | 1985-01-18 | 1993-10-19 | Plant Genetic Systems N.V. | Transformation vectors allowing expression of Bacillus thuringiensis endotoxins in plants |
| DE3715114A1 (de) * | 1987-05-06 | 1988-11-17 | Krause Hans | Verfahren und einrichtung zum toxizitaetsnachweis in oberflaechengewaessern sowie in trink- und brauchwasser |
| GB9206648D0 (en) | 1992-03-26 | 1992-05-06 | Leo Pharm Prod Ltd | Chemical compounds |
| US5665555A (en) * | 1993-12-15 | 1997-09-09 | Academy Of Natural Sciences Of Philadelphia | Method of determining the effect of a test substance on a clone of a Centroptilum triangulifer mayfly |
| AU728037B2 (en) * | 1997-05-22 | 2001-01-04 | Cephalon, Inc. | Vitamin D analogues and their neuronal effects |
-
2000
- 2000-07-11 HU HU0202305A patent/HUP0202305A3/hu unknown
- 2000-07-11 DK DK00943703T patent/DK1206448T3/da active
- 2000-07-11 CN CNB008123454A patent/CN1167678C/zh not_active Expired - Fee Related
- 2000-07-11 JP JP2001515296A patent/JP2003506435A/ja active Pending
- 2000-07-11 ES ES00943703T patent/ES2216908T3/es not_active Expired - Lifetime
- 2000-07-11 PL PL00364698A patent/PL364698A1/xx not_active Application Discontinuation
- 2000-07-11 AU AU58072/00A patent/AU770771B2/en not_active Ceased
- 2000-07-11 DE DE60010276T patent/DE60010276T2/de not_active Expired - Fee Related
- 2000-07-11 RU RU2002105520/04A patent/RU2228928C2/ru not_active IP Right Cessation
- 2000-07-11 WO PCT/DK2000/000389 patent/WO2001010829A1/en active IP Right Grant
- 2000-07-11 PT PT00943703T patent/PT1206448E/pt unknown
- 2000-07-11 US US10/048,363 patent/US6573255B1/en not_active Expired - Fee Related
- 2000-07-11 AT AT00943703T patent/ATE265430T1/de not_active IP Right Cessation
- 2000-07-11 EP EP00943703A patent/EP1206448B1/en not_active Expired - Lifetime
- 2000-07-11 KR KR1020027001539A patent/KR20020022792A/ko not_active Application Discontinuation
- 2000-07-11 NZ NZ516913A patent/NZ516913A/en unknown
- 2000-07-11 CA CA002381910A patent/CA2381910A1/en not_active Abandoned
- 2000-07-11 CZ CZ2002392A patent/CZ2002392A3/cs unknown
- 2000-07-31 JP JP2001515324A patent/JP4971571B2/ja not_active Expired - Fee Related
-
2003
- 2003-02-18 HK HK03101142.2A patent/HK1049148B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1049148B (zh) | 2005-03-11 |
| AU5807200A (en) | 2001-03-05 |
| EP1206448B1 (en) | 2004-04-28 |
| ES2216908T3 (es) | 2004-11-01 |
| CN1167678C (zh) | 2004-09-22 |
| PT1206448E (pt) | 2004-08-31 |
| RU2228928C2 (ru) | 2004-05-20 |
| DE60010276T2 (de) | 2005-04-21 |
| WO2001010829A1 (en) | 2001-02-15 |
| PL364698A1 (en) | 2004-12-13 |
| HK1049148A1 (en) | 2003-05-02 |
| JP2003506067A (ja) | 2003-02-18 |
| CA2381910A1 (en) | 2001-02-15 |
| US6573255B1 (en) | 2003-06-03 |
| DE60010276D1 (de) | 2004-06-03 |
| HUP0202305A2 (en) | 2002-10-28 |
| JP2003506435A (ja) | 2003-02-18 |
| AU770771B2 (en) | 2004-03-04 |
| JP4971571B2 (ja) | 2012-07-11 |
| ATE265430T1 (de) | 2004-05-15 |
| CZ2002392A3 (cs) | 2002-11-13 |
| NZ516913A (en) | 2003-11-28 |
| HUP0202305A3 (en) | 2003-10-28 |
| EP1206448A1 (en) | 2002-05-22 |
| KR20020022792A (ko) | 2002-03-27 |
| CN1372544A (zh) | 2002-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1116845T1 (el) | S-φθορομεθυλεστερας του 6.αλφα.,9.αλφα.-διφθορο-17.αλφα.-[(2-φουρανυλοκαρβονυλ)οξυ]-11.βητα.-υδροξυ-16.αλφα.-μεθυλ-3-οξο-ανδροστ-1,4,-διενο-17-καρβοθειοϊκου οξεος ως ενας αντι-φλεγμονωδης παραγοντας | |
| DK0984778T3 (da) | Neuropeptid-Y-ligander | |
| KR100263496B1 (ko) | 탁솔 유도체 및 이의 제조방법 | |
| RU2008132204A (ru) | Соединения для лечения метаболических заболеваний | |
| CY1113054T1 (el) | Παραγωγα διαμινης | |
| ATE407155T1 (de) | Pyridin-imin polymerisationskatalysator | |
| DK0892780T3 (da) | m-Amidinophenylanaloger som faktor Xa-inhibitorer | |
| CY1106827T1 (el) | Παραγωγα ν-[φαινυλιο(πυρρολιδιν-2-υλιο)μεθυλιο]βενζαμιδη, και ν-[(αζεπαν-2-υλιο)φαινυλομεθυλιο]βενζαμιδη, η παρασκευη του και η εφαρμογη τους στην θεραπευτικη. | |
| SG165361A1 (en) | Antituberculous composition comprising oxazole compounds | |
| CY1107662T1 (el) | Μεθοδος παρασκευης της (ε, ζ) 3-(2-aminoethoxyimino)-androstane-6,17-dione και αναλογων της | |
| ES2175989T3 (es) | Derivado de testosterona. | |
| HK1045990A1 (en) | Novel derivatives and analogues of galanthamin. | |
| DE69724646D1 (de) | 16-ene-vitamin d derivate | |
| DK1206448T3 (da) | Nye vitamin D analoger | |
| AR004965A1 (es) | Procedimiento de preparacion de derivados de fenilimidazolidina | |
| TR200100740T2 (tr) | Tiyazolilsinnamonitriller ve haşere kontrol edici ajanlar | |
| AP2001002045A0 (en) | FKBP inhibitors. | |
| AU2002334726A1 (en) | Alkyl-succinhydrazide additives for lubricants | |
| DE59703603D1 (de) | Pteridinderivate als NO Synthase-Hemmer | |
| DK0963998T3 (da) | Azasteroidforbindelse til behandling eller prævention af prostatacancer | |
| ES8507525A1 (es) | Procedimiento para preparar 3-acil-2-nitrometilentetrahidro-2h-1, 3-tiazinas | |
| TR199901284A2 (xx) | Ester bile�imleri. | |
| DK1140932T3 (da) | Derivater af benzo-1,8-naphtyridin | |
| ES2184311T3 (es) | Polioxaalcanocarboxilatos de estaño y composiciones que los contienen. | |
| ATE238781T1 (de) | Verwendung von katecholderivaten als proteinaseinhibitoren |